Predictive factors in breast cancer

por Klijn, J, Berns, E, Dorssers, L, Foekens, J
Publicado 2000

Effects of suramin on cell-cycle kinetics of MCF-7 human breast cancer cells in vitro.

por Foekens, J. A., Sieuwerts, A. M., Stuurman-Smeets, E. M., Peters, H. A., Klijn, J. G.
Publicado 1993

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

por Verhoog, L C, Brekelmans, C T M, Seynaeve, C, Meijers-Heijboer, E J, Klijn, J G M
Publicado 2000

Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.

por Henzen-Logmans, S. C., Berns, E. M., Klijn, J. G., van der Burg, M. E., Foekens, J. A.
Publicado 1992

Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease

por Foekens, J A, Ries, Ch, Look, M P, Gippner-Steppert, C, Klijn, J G M, Jochum, M
Publicado 2003

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.

por Klijn, J. G., Hoff, A. M., Planting, A. S., Verweij, J., Kok, T., Lamberts, S. W., Portengen, H., Foekens, J. A.
Publicado 1990

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer.

por Berns, E. M., Klijn, J. G., Smid, M., van Staveren, I. L., Gruis, N. A., Foekens, J. A.
Publicado 1995

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.

por Berns, E. M., van Staveren, I. L., Look, M. P., Smid, M., Klijn, J. G., Foekens, J. A.
Publicado 1998

Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases.

por Peters, W. H., Roelofs, H. M., van Putten, W. L., Jansen, J. B., Klijn, J. G., Foekens, J. A.
Publicado 1993

Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer.

por Foekens, J. A., Portengen, H., Look, M. P., van Putten, W. L., Thirion, B., Bontenbal, M., Klijn, J. G.
Publicado 1994

Effect of hormonal manipulation and doxorubicin administration on cell cycle kinetics of human breast cancer cells.

por Bontenbal, M., Sieuwerts, A. M., Klijn, J. G., Peters, H. A., Krijnen, H. L., Sonneveld, P., Foekens, J. A.
Publicado 1989

Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.

por Romain, S., Chinot, O., Klijn, J. G., van Putten, W. L., Guirou, O., Look, M., Martin, P. M., Foekens, J. A.
Publicado 1994

Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer

por Foekens, J A, Diamandis, E P, Yu, H, Look, M P, Gelder, M E Meijer-van, Klijn, J G M
Publicado 1999

Stromal influences on breast cancer cell growth.

por van Roozendaal, C. E., van Ooijen, B., Klijn, J. G., Claassen, C., Eggermont, A. M., Henzen-Logmans, S. C., Foekens, J. A.
Publicado 1992

Allelotype of 28 human breast cancer cell lines and xenografts

por Harkes, I C, Elstrodt, F, Dinjens, W N M, Molier, M, Klijn, J G M, Berns, E M J J, Schutte, M
Publicado 2003

Advanced breast cancer and its prevention by screening.

por de Koning, H. J., van Ineveld, B. M., de Haes, J. C., van Oortmarssen, G. J., Klijn, J. G., van der Maas, P. J.
Publicado 1992

Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours.

por Schuyer, M., van Staveren, I. L., Klijn, J. G., vd Burg, M. E., Stoter, G., Henzen-Logmans, S. C., Foekens, J. A., Berns, E. M.
Publicado 1996

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group.

por Bontenbal, M., Andersson, M., Wildiers, J., Cocconi, G., Jassem, J., Paridaens, R., Rotmensz, N., Sylvester, R., Mouridsen, H. T., Klijn, J. G., van Oosterom, A. T.
Publicado 1998

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients

por Foekens, J A, Look, M P, Vries, J Bolt-de, Gelder, M E Meijer-van, Putten, W L J van, Klijn, J G M
Publicado 1999

Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cance...

por Bontenbal, M., Foekens, J. A., Lamberts, S. W., de Jong, F. H., van Putten, W. L., Braun, H. J., Burghouts, J. T., van der Linden, G. H., Klijn, J. G.
Publicado 1998